Market Overview

Goldman Says FDA Response to Energy Drink Safety Review 'Encouraging' for Monster

Share:
Related MNST
Fast Money Halftime Report Final Trade From March 19
Credit Suisse Hikes Monster Beverage Price Target 30%
Monster, WhiteWave Become IBD 50 Takeover Prospects (Investor's Business Daily)

Commenting on the action in Monster Beverage this afternoon, Goldman Sachs analyst Judy Hong called the FDA's response to the energy drink safety issue "generally benign." Hong believes this should be encouraging for Monster. The analyst believes the most likely outcome related to Durbin's energy drink review will be strong labeling, something which is unlikely to have a material impact on Monster.

Latest Ratings for MNST

DateFirmActionFromTo
Mar 2015CitigroupMaintainsNeutral
Feb 2015CitigroupMaintainsNeutral
Feb 2015JefferiesMaintainsHold

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings Movers

 

Related Articles (MNST)

Around the Web, We're Loving...